Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: A systematic review of preclinical evidence

This publication has 70 references indexed in Scilit:

• Baicalin’s Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative EffectsIn VitroandIn Vivo
  Evidence-Based Complementary and Alternative Medicine, 2013
• FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
  British Journal of Pharmacology, 2009
• Oxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options
  Journal of Human Hypertension, 2009
• Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions
  Annals of Neurology, 2009
• Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-β
  Journal of Neuroinflammation, 2009
• Quercetin and interferon-β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients
  Journal of Neuroimmunology, 2008
• Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cells
  British Journal of Pharmacology, 2008
• Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
  Brain, 2007
• Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-κB Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-κB Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated Macrophages
  Mediators of Inflammation, 2007
• Antioxidant and Prooxidant Effects of Phenolics on Pancreatic β-Cells in Vitro
  Journal of Agricultural and Food Chemistry, 2002